Search research articles
Contact Us
Filters
Showing results (31-40 of 121) with videos related to
Page
of 13
Sort By:
Dermatology and Therapy
|
January 12, 2023
Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment
Raquel Rivera-Díaz, Esteban Daudén, José Manuel Carrascosa, et al.
Dermatology (Basel, Switzerland)
|
January 31, 2015
Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature
Alba Català, Esther Roé, Joan Dalmau, et al.
European Journal of Dermatology : EJD
|
April 17, 2010
Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate
Anna López-Ferrer, Luis Puig, Gerardo Moreno, et al.
Dermatology and Therapy
|
September 14, 2023
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review
Giampiero Girolomoni, Laura Savage, Paolo Gisondi, et al.
Archives of Dermatological Research
|
April 17, 2013
National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines
Alexander Nast, Ulrich Mrowietz, Knud Kragballe, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
January 1, 2013
[Papillary thyroid microcarcinoma diagnosed based on cyst-like mediastinal metastasis]
Eduardo Néstor Faure, Ana Julia González, Diego Schwarzstein, et al.
The Journal of Dermatological Treatment
|
December 3, 2024
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Giampiero Girolomoni, Steven R Feldman, Alexander Egeberg, et al.
Experimental Dermatology
|
November 29, 2020
LRP1/CD91 is highly expressed in monocytes from patients with vitiligo - even after repigmentation
Jaime Piquero-Casals, Laura Martínez-Martínez, Agustín Alomar, et al.
Dermatology and Therapy
|
May 21, 2021
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model
Kim A Papp, Ahmed M Soliman, Nicolae Done, et al.
Drugs in R&D
|
June 9, 2021
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
Reinhart Speeckaert, Jo Lambert, Luis Puig, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 121) with videos related to
Sort By:
Page
of 13
Dermatology and Therapy
|
January 12, 2023
Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment
Raquel Rivera-Díaz, Esteban Daudén, José Manuel Carrascosa, et al.
Dermatology (Basel, Switzerland)
|
January 31, 2015
Anti-tumour necrosis factor-induced visceral and cutaneous leishmaniasis: case report and review of the literature
Alba Català, Esther Roé, Joan Dalmau, et al.
European Journal of Dermatology : EJD
|
April 17, 2010
Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate
Anna López-Ferrer, Luis Puig, Gerardo Moreno, et al.
Dermatology and Therapy
|
September 14, 2023
Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review
Giampiero Girolomoni, Laura Savage, Paolo Gisondi, et al.
Archives of Dermatological Research
|
April 17, 2013
National and multinational guidelines in Europe: results from an online survey on awareness of different national and European psoriasis guidelines
Alexander Nast, Ulrich Mrowietz, Knud Kragballe, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion
|
January 1, 2013
[Papillary thyroid microcarcinoma diagnosed based on cyst-like mediastinal metastasis]
Eduardo Néstor Faure, Ana Julia González, Diego Schwarzstein, et al.
The Journal of Dermatological Treatment
|
December 3, 2024
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
Giampiero Girolomoni, Steven R Feldman, Alexander Egeberg, et al.
Experimental Dermatology
|
November 29, 2020
LRP1/CD91 is highly expressed in monocytes from patients with vitiligo - even after repigmentation
Jaime Piquero-Casals, Laura Martínez-Martínez, Agustín Alomar, et al.
Dermatology and Therapy
|
May 21, 2021
Deterioration of Health-Related Quality of Life After Withdrawal of Risankizumab Treatment in Patients with Moderate-to-Severe Plaque Psoriasis: A Machine Learning Predictive Model
Kim A Papp, Ahmed M Soliman, Nicolae Done, et al.
Drugs in R&D
|
June 9, 2021
Vaccinations in Patients Receiving Systemic Drugs for Skin Disorders: What Can We Learn for SARS-Cov-2 Vaccination Strategies?
Reinhart Speeckaert, Jo Lambert, Luis Puig, et al.
Page
of 13